HomeGTBP • NASDAQ
add
GT Biopharma Inc
Previous close
$2.42
Day range
$2.43 - $2.56
Year range
$1.92 - $10.66
Market cap
5.68M USD
Avg Volume
15.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.91M | 7.87% |
Net income | -3.71M | -86.24% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.25M | -48.54% |
Total assets | 9.27M | -48.93% |
Total liabilities | 3.76M | -41.09% |
Total equity | 5.51M | — |
Shares outstanding | 2.23M | — |
Price to book | 0.98 | — |
Return on assets | -101.83% | — |
Return on capital | -180.00% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -3.71M | -86.24% |
Cash from operations | -3.54M | -82.74% |
Cash from investing | 7.86M | 195.78% |
Cash from financing | 2.98M | — |
Net change in cash | 7.30M | 910.94% |
Free cash flow | -3.07M | -176.10% |
About
Founded
1965
Headquarters
Website
Employees
2